학술논문

Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
Document Type
Article
Source
In The Lancet Oncology July 2016 17(7):984-993
Subject
Primary Research
Articles
Language
ISSN
1470-2045